Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 20

1.

Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination.

Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, Mejima M, Nakanishi U, Matsumura A, Uozumi A, Hiroi T, Morita S, Tanaka K, Takaiwa F, Kiyono H.

Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):10986-91. Epub 2007 Jun 15.

2.

Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.

Moravec T, Schmidt MA, Herman EM, Woodford-Thomas T.

Vaccine. 2007 Feb 19;25(9):1647-57. Epub 2006 Nov 17.

PMID:
17188785
3.

Roundtrip ticket for secretory IgA: role in mucosal homeostasis?

Corth├ęsy B.

J Immunol. 2007 Jan 1;178(1):27-32. Review.

4.

Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein.

Zhang X, Buehner NA, Hutson AM, Estes MK, Mason HS.

Plant Biotechnol J. 2006 Jul;4(4):419-32.

5.

Delivery systems and adjuvants for oral vaccines.

Lavelle EC, O'Hagan DT.

Expert Opin Drug Deliv. 2006 Nov;3(6):747-62. Review.

PMID:
17076597
6.

Plant-made vaccines: biotechnology and immunology in animal health.

Rice J, Ainley WM, Shewen P.

Anim Health Res Rev. 2005 Dec;6(2):199-209. Review.

PMID:
16583782
7.

Needle-free vaccine delivery.

Giudice EL, Campbell JD.

Adv Drug Deliv Rev. 2006 Apr 20;58(1):68-89. Epub 2006 Mar 24. Review.

PMID:
16564111
8.

A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses.

Takagi H, Hiroi T, Yang L, Tada Y, Yuki Y, Takamura K, Ishimitsu R, Kawauchi H, Kiyono H, Takaiwa F.

Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17525-30. Epub 2005 Nov 8.

9.

Synthesis and assembly of a cholera toxin B subunit-rotavirus VP7 fusion protein in transgenic potato.

Choi NW, Estes MK, Langridge WH.

Mol Biotechnol. 2005 Nov;31(3):193-202.

PMID:
16230769
10.

Targeted vaccine adjuvants based on modified cholera toxin.

Lycke N.

Curr Mol Med. 2005 Sep;5(6):591-7. Review.

PMID:
16178769
11.

Regulatory issues for plant-made pharmaceuticals and vaccines.

Streatfield SJ.

Expert Rev Vaccines. 2005 Aug;4(4):591-601. Review.

PMID:
16117714
12.

Plant-based vaccines for animal health.

Streatfield SJ.

Rev Sci Tech. 2005 Apr;24(1):189-99. Review.

PMID:
16110888
13.

Expression and immunogenicity of an Escherichia coli K99 fimbriae subunit antigen in soybean.

Piller KJ, Clemente TE, Jun SM, Petty CC, Sato S, Pascual DW, Bost KL.

Planta. 2005 Sep;222(1):6-18. Epub 2004 Dec 18.

PMID:
15609046
14.

Revolutionary vaccine technology breaks the cold chain.

Das P.

Lancet Infect Dis. 2004 Dec;4(12):719. No abstract available.

PMID:
15593445
15.

Garden-variety vaccines: antigens derived from transgenic plants.

Tacket CO.

Expert Rev Vaccines. 2004 Oct;3(5):529-31. Review.

PMID:
15485332
16.

Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn.

Tacket CO, Pasetti MF, Edelman R, Howard JA, Streatfield S.

Vaccine. 2004 Oct 22;22(31-32):4385-9.

PMID:
15474732
17.

Edible genetically modified microorganisms and plants for improved health.

Mercenier A, Wiedermann U, Breiteneder H.

Curr Opin Biotechnol. 2001 Oct;12(5):510-5. Review.

PMID:
11604330
18.
19.

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice.

Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK, Arntzen CJ.

Proc Natl Acad Sci U S A. 1996 May 28;93(11):5335-40.

20.

Expression of hepatitis B surface antigen in transgenic plants.

Mason HS, Lam DM, Arntzen CJ.

Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11745-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk